Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. NOW
7. GM
8. SMCI
9. GOOGL
10. TSLA

Go back to Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
(NASDAQ: DFTX) Delayed: 43.67 -1.41 (3.13%)
Previous Close $45.08    52 Week High $ 
Open $44.02    52 Week Low $ 
Day High $44.99    P/E N/A 
Day Low $43.53    EPS $ 
Volume 1,239,538